Freezing threatens mRNA delivery, but Tris buffer helps nanoparticles retain their potency
Researchers at The University of Texas at Austin have teamed up with pharmaceutical company Eli Lilly and Company to uncover how storage conditions affect mRNA lipid nanoparticles (LNPs), the technology behind COVID-19 vaccines and other…
Read the full story at Phys.org ↗
ImpactMinor 28/100
Why it mattersRule-based estimate: no strong signals; trust 6/10.
RegionsGlobal
Published4 h ago (Fri, 25 Sep 2026 17:40:05 GMT)
RetrievedFri, 25 Sep 2026 18:00:29 GMT via rss
ClassifiedFri, 25 Sep 2026 18:00:59 GMT by heuristic